Ebola outbreak in Congo
Analysis based on 42 articles · First reported Jul 14, 2026 · Last updated Jul 15, 2026
The outbreak strains healthcare systems in the region and may disrupt mining operations in eastern DRC, potentially affecting commodity supply chains. Pharmaceutical companies involved in Ebola treatment trials could see increased attention and investment.
The Democratic Republic of the Congo is experiencing its fastest-growing Ebola outbreak on record, caused by the rare Bundibugyo virus. As of July 15, 2026, confirmed cases have reached 2,011, including 754 deaths, according to the Ministry of Public Health. The World Health Organization estimates the true scale may be two to four times larger. Health workers at treatment centers in Democratic Republic of the Congo — Ituri Province, including Democratic Republic of the Congo — Bunia and Rwampara, have gone on strike over unpaid salaries and bonuses, complicating response efforts. The outbreak has spread to five provinces: Ituri, Democratic Republic of the Congo — North Kivu, Democratic Republic of the Congo — South Kivu, Democratic Republic of the Congo — Tshopo, and Democratic Republic of the Congo — Haut-Uélé. Uganda has reported 20 cases, including two deaths. No approved vaccine or treatment exists for the Bundibugyo strain, but a clinical trial of two possible treatments has begun. The international community has raised $1.5 billion for the response.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard